ChemT, a Singapore-based biotech company using AI for biomanufacturing, raised $4 million in a Seed round led by Wavemaker Ventures and SEEDS. The company plans to expand its CelMo virtual cell model platform and advance AI-designed molecular products toward regulatory readiness.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
Bionyra Pharma Raises $165M in Series A Funding